Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum LSL Pharma Group Inc LPGIF


Primary Symbol: V.LSL Alternate Symbol(s):  V.LSL.DB

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company. The Company is specialized in the development, manufacturing and commercialization of sterile ophthalmic pharmaceuticals, as well as natural health products in solid and liquid dosage forms. It specializes in the manufacturing and marketing of natural health products (NHPs). The Company manufactures a range of NHPs in liquid... see more

TSXV:LSL - Post Discussion

LSL Pharma Group Inc > web site 2 divisions LSL Pharma
View:
Post by Luxieuxone on Mar 01, 2023 10:53am

web site 2 divisions LSL Pharma

https://www.laboratoirelsl.com/?lang=en

&

https://sterimedpharma.com/en/home/
Comment by Brudom2002 on Mar 01, 2023 11:02am
Je crois galement qu'il y a un bon potentiel mais ce matin, il y en a un qui tait dans le financement et qui voudrait absolument qu'il y ait des ventes 1,00$. Pas srieux
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities